Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen to Market ProteinChip in China

NEW YORK, Feb. 19 - Ciphergen Biosystems has gained a toehold in China after it sold its ProteinChip systems to hospitals, universities, and government agencies in that country, the company said on Tuesday. 

 

Ciphergen has also established a formal relationship with the Universities Confederated Institute for Proteomics, which the Chinese government established in May 2001. 

 

"The Chinese government has publicly stated that it intends to foster proteomics research and China is therefore potentially a very significant market for Ciphergen," William E. Rich, president and CEO of the Fremont, Calif.-based company, said in a statement.

 

Dacheng He, chief scientist and deputy director of UCIP, commented that he is "optimistic" that his group will be able to discover "a number of protein biomarkers that will be useful as predictive diagnostics, as well as providing insights into disease pathways."

 

Ciphergen's ProteinChip system is designed to be used for protein discovery, characterization, and assay development. 

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.